2-(氯甲基)苯甲酰氯 | 42908-86-1

• 物质功能分类: 化学试剂 - 有机试剂 - 酰卤
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-(氯甲基)苯甲酰氯
• 中文别名: 邻氯甲基苯甲酰氯
• 英文名称: 2-Chloromethylbenzoyl chloride
• 英文别名: 2-(Chloromethyl)benzoyl chloride
• CAS: 42908-86-1
• 化学式: C₈H₆Cl₂O
• mdl: MFCD00152348
• 分子量: 189.041
• InChiKey: TXZFBHYDQGYOIT-UHFFFAOYSA-N

物化性质

• 熔点：
  17°C(lit.)
• 沸点：
  265°C(lit.)
• 密度：
  1.317±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  F,Xi
• WGK Germany：
  3
• 海关编码：
  2916399090
• 危险类别：
  3.1
• 安全说明：
  S16,S26,S36
• 危险类别码：
  R36/37/38,R11
• 包装等级：
  II
• 危险品运输编号：
  UN 3271 3/PG 2
• 危险性防范说明：
  P261,P280,P305+P351+P338,P310
• 危险性描述：
  H302,H314,H331,H351
• 储存条件：
  存放于惰性气体中，并避免接触湿气（以免发生分解）。

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 2-(Chloromethyl)benzoyl chloride
CAS-No. : 42908-86-1
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Acute toxicity, Oral (Category 4)
Acute toxicity, Inhalation (Category 3)
Skin corrosion (Category 1B)
Carcinogenicity (Category 2)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Harmful if swallowed. Toxic by inhalation. Causes burns. Limited evidence of a carcinogenic effect.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Danger
Hazard statement(s)
H302 Harmful if swallowed.
H314 Causes severe skin burns and eye damage.
H331 Toxic if inhaled.
H351 Suspected of causing cancer.
Precautionary statement(s)
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P280 Wear protective gloves/ protective clothing/ eye protection/ face
protection.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
P310 Immediately call a POISON CENTER or doctor/ physician.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R22 Harmful if swallowed.
R23 Toxic by inhalation.
R34 Causes burns.
R40 Limited evidence of a carcinogenic effect.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
S36/37/39 Wear suitable protective clothing, gloves and eye/face protection.
S45 In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C8H6Cl2O
Molecular Weight : 189,04 g/mol
Component Concentration
2-(Chloromethyl)benzoyl chloride
CAS-No. 42908-86-1 -
EC-No. 255-998-2

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Take victim
immediately to hospital. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with water.
Consult a physician.
Most important symptoms and effects, both acute and delayed
Material is extremely destructive to tissue of the mucous membranes and upper respiratory tract, eyes, and
skin.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIRE-FIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Hydrogen chloride gas
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate
personnel to safe areas.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Hydrolyses readily. Moisture sensitive. hygroscopic Store under inert gas.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling the
product.
Personal protective equipment
Eye/face protection
Tightly fitting safety goggles. Faceshield (8-inch minimum). Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the
standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator with
multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup to
engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: clear, liquid
Colour: colourless
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and 135 °C at 0 hPa
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
Suspected human carcinogens
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation
Toxic if inhaled. Material is extremely destructive to the tissue of the
mucous membranes and upper respiratory tract.
Ingestion
Harmful if swallowed. Causes burns.
Skin May be harmful if absorbed through skin. Causes skin burns.
Eyes Causes eye burns.
Signs and Symptoms of Exposure
Material is extremely destructive to tissue of the mucous membranes and upper respiratory tract, eyes, and
skin.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: 2927 IMDG: 2927 IATA: 2927
UN proper shipping name
ADR/RID: TOXIC LIQUID, CORROSIVE, ORGANIC, N.O.S. (2-(Chloromethyl)benzoyl chloride)
IMDG: TOXIC LIQUID, CORROSIVE, ORGANIC, N.O.S. (2-(Chloromethyl)benzoyl chloride)
IATA: Toxic liquid, corrosive, organic, n.o.s. (2-(Chloromethyl)benzoyl chloride)
Transport hazard class(es)
ADR/RID: 6.1 (8) IMDG: 6.1 (8) IATA: 6.1 (8)
Packaging group
ADR/RID: II IMDG: II IATA: II
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2011 Co. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Co., shall not be held liable for any damage
resulting from handling or from contact with the above product. See reverse side of invoice or packing slip
for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  2-(氯甲基)苯甲酰氯 在 三乙胺 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 以89%的产率得到2-氯甲基苯甲酸甲酯
  参考文献：
  名称：

  Process for preparing o-(carboalkoxy)phenylmethanesulfonyl chloride derivatives

  摘要：

  制备公式（1）的o-(羧基烷氧基)苯基甲磺酰氯衍生物的方法，其中：X选择自氢原子、卤素原子、C1至C6烷基、C1至C6卤代烷基、C1至C6烷氧基、C1至C6烷氧羰基、硝基和苯基；R选择自C1至C6烷基、C1至C6卤代烷基和C3至C6环烷基；n选择自1至4的整数。

  公开号：

  US06222060B1
• 作为产物：
  描述：

  苯酞 在 三光气 作用下， 生成 2-(氯甲基)苯甲酰氯
  参考文献：
  名称：

  Kresoxim-甲基衍生物：（吡啶基苯氧基亚甲基）苯基甲氧基亚氨基乙酸酯的合成和除草活性

  摘要：

  合成了一系列新的kresoxim-甲基衍生物，（吡啶基苯氧基亚甲基）苯基甲氧基亚氨基乙酸酯，并通过NMR和高分辨率质谱（HRMS）证实了它们的结构。尽管是从杀菌剂中提取的，但生物测定结果表明，几种新化合物具有良好的除草活性。在37.5 g ai / ha的条件下，化合物5c表现出对百草枯，，菜和梨形喜豆（Eclipta prostrata）的100％抑制作用，优于甲基磺草酮。化合物5e对阔叶杂草具有广泛的除草谱。目前的工作表明5c和5e可以作为潜在除草剂的新候选者。

  DOI：

  10.1021/acs.jafc.7b02710

文献信息

• Diphenyl ether derivatives and herbicides containing same
  申请人：Mitsui Toatsu Chemicals, Inc.

  公开号：US04515628A1

  公开（公告）日：1985-05-07

  Novel diphenyl ether hydrazine derivatives, particularly 2-nitro-5 (nucleus-substituted phenoxy) phenylhydrazine derivatives are provided. They are useful as a selective herbicide having a high herbicidal acitivity and residual efficacy.

  新型二苯醚肼衍生物，特别是2-硝基-5（核取代苯氧基）苯基肼衍生物已提供。它们作为一种具有高除草活性和残留效果的选择性除草剂是有用的。
• Substituted benzazoles and methods of their use as inhibitors of Raf kinase
  申请人：——

  公开号：US20040122237A1

  公开（公告）日：2004-06-24

  New substituted benz-azole compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.

  提供了新的替代苯唑化合物、组合物和抑制人类或动物主体中Raf激酶活性的方法。这些新化合物组合物可以单独使用，也可以与至少一种额外药物结合，用于治疗由Raf激酶介导的疾病，如癌症。
• PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS
  申请人：CHEMOCENTRYX, INC.

  公开号：US20190300526A1

  公开（公告）日：2019-10-03

  The present disclosure provides, inter alia, Compounds of Formulae IA, IB, IC, IIA, IIB and IIC or pharmaceutically acceptable salts thereof that are modulators of the C5a receptor. Also provided are pharmaceutical compositions and methods of use including the treatment of diseases or disorders involving pathologic activation from C5a and non-pharmaceutical applications.

  本公开提供了化合物IA、IB、IC、IIA、IIB和IIC的结构，或其在药学上可接受的盐，这些化合物是C5a受体的调节剂。还提供了包括治疗涉及C5a病理性激活的疾病或疾病的药物组合物和使用方法，以及非药物应用。
• Synthetic studies on 2,4-benzothiazepin-5(1H)-one and 2,4-benzodiazepin-1-one derivatives.
  作者：HIROSHI FUJITA、YASUNOBU SATO

  DOI：10.1248/cpb.23.1764

  日期：——

  2, 4-Benzothiazepin-5 (1H)-one were usually the predominant products in reactions of o-chloromethylbenzoyl chloride with 1, 3-disubstituted thioureas ; but with methyl, benzyl or allyl substituted thioureas, 2, 4-benzodiazepin-1-ones were obtained together with 2, 4-benzothiazepin-5 (1H)-ones. These structures were elucidated from infrared, ultraviolet and nuclear magnetic resonance spectra. We also found that nature of the base and solvent as well as thiourea substituents affected the course of the reactions affording 2, 4-benzothiazepin-5 (1H)-ones or 2, 4-benzodiazepin-1-ones. Several 2, 4-benzothiazepin-5 (1H)-ones and 2, 4-benzodiazepin-1-ones possessed weak pharmacological activities, such as coronary vasodilating and local anesthetic activity.

  2, 4-苯并噻嗪-5(1H)-酮通常是邻氯甲基苯甲酰氯与1,3-双取代硫脲反应中的主要产物；但当硫脲含有甲基、苄基或烯丙基取代基时，会同时得到2, 4-苯并二氮杂䓬-1-酮与2, 4-苯并噻嗪-5(1H)-酮。这些结构通过红外、紫外和核磁共振光谱得以阐明。我们还发现，碱和溶剂的性质以及硫脲的取代基会影响反应的进程，从而生成2, 4-苯并噻嗪-5(1H)-酮或2, 4-苯并二氮杂䓬-1-酮。一些2, 4-苯并噻嗪-5(1H)-酮和2, 4-苯并二氮杂䓬-1-酮具有较弱的药理活性，如冠状动脉舒张和局部麻醉作用。
• [EN] EFFICIENT ASPIRIN PRODRUGS<br/>[FR] PROMÉDICAMENTS EFFICACES DE L'ASPIRINE
  申请人：TRINITY COLLEGE DUBLIN

  公开号：WO2009080795A1

  公开（公告）日：2009-07-02

  Aspirin is one of the most widely used drugs in the treatment of inflammation, pain and fever. It has more recently found application in the prevention of heart attacks and stroke and is being studied as a cancer chemopreventative agent. Despite its value aspirin continues to be underutilized because it causes gastric bleeding. The technology under development potentially removes this problem. It is designed to reduce contact between the drug and the intestinal lining. An isosorbide aspirinate prodrug compound is thus provided. The compound has the general structure as shown in general formula (I) wherein Y is a C1 - C8 alkyl ester, a C1 - C8 alkoxy ester, a C3 - C10 cycloalkyl ester, an arylester, a C1 - C8 alkylaryl ester or -C(O)ORring, wherein Rring is a 5-membered aromatic or nonaromatic 5-member ring having at least one heteroatom substituted for a carbon of the ring system, which can be unsubstituted or substituted with at least one nitric oxide releasing group.

  阿司匹林是治疗炎症、疼痛和发热最广泛使用的药物之一。它最近在预防心脏病和中风方面找到了应用，并且正在作为抗癌化学预防剂进行研究。尽管阿司匹林具有价值，但由于它会导致胃出血，因此其使用仍然不足。正在开发中的技术可能解决了这个问题。该技术旨在减少药物与肠粘膜的接触。因此，提供了一种异山梨醇阿司匹林前药化合物。该化合物的通用结构如通用公式(I)所示，其中Y是C1 - C8烷基酯，C1 - C8烷氧基酯，C3 - C10环烷基酯，芳基酯，C1 - C8烷基芳基酯或-C(O)ORring，其中Rring是具有至少一个杂原子代替环系统中的碳的5元芳香或非芳香5元环，该环可以是未取代的或至少取代有一个释放一氧化氮的基团。